142 related articles for article (PubMed ID: 24344031)
1. Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain.
Kanat O; Bagdas D; Ozboluk HY; Gurun MS
J BUON; 2013; 18(4):1012-8. PubMed ID: 24344031
[TBL] [Abstract][Full Text] [Related]
2. The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
Bagdas D; Sonat FA; Hamurtekin E; Sonal S; Gurun MS
Behav Pharmacol; 2011 Sep; 22(5-6):589-98. PubMed ID: 21836465
[TBL] [Abstract][Full Text] [Related]
3. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
4. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
Gurun MS; Parker R; Eisenach JC; Vincler M
Anesth Analg; 2009 May; 108(5):1680-7. PubMed ID: 19372354
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
6. Choline, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous system.
Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
Eur J Pharmacol; 2008 Jul; 589(1-3):315-22. PubMed ID: 18561911
[TBL] [Abstract][Full Text] [Related]
7. Role of central arginine vasopressin receptors in the analgesic effect of CDP-choline on acute and neuropathic pain.
Bagdas D; Yucel-Ozboluk H; Orhan F; Kanat O; Isbil-Buyukcoskun N; Gurun MS
Neuroreport; 2013 Dec; 24(17):941-6. PubMed ID: 24089014
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
Savci V; Cavun S; Goktalay G; Ulus IH
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
[TBL] [Abstract][Full Text] [Related]
9. Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation.
Cavun S; Savci V; Ulus IH
Fundam Clin Pharmacol; 2004 Feb; 18(1):71-7. PubMed ID: 14748757
[TBL] [Abstract][Full Text] [Related]
10. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations.
Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH
Auton Autacoid Pharmacol; 2008 Jan; 28(1):41-58. PubMed ID: 18257750
[TBL] [Abstract][Full Text] [Related]
11. CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement.
Cavun S; Savci V
Fundam Clin Pharmacol; 2004 Oct; 18(5):513-23. PubMed ID: 15482372
[TBL] [Abstract][Full Text] [Related]
12. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions.
Ilcol YO; Cansev M; Yilmaz MS; Hamurtekin E; Ulus IH
Neurosci Lett; 2008 Jan; 431(1):71-6. PubMed ID: 18162319
[TBL] [Abstract][Full Text] [Related]
13. The effect of centrally injected CDP-choline on respiratory system; involvement of phospholipase to thromboxane signaling pathway.
Topuz BB; Altinbas B; Yilmaz MS; Saha S; Batten TF; Savci V; Yalcin M
Respir Physiol Neurobiol; 2014 May; 195():50-8. PubMed ID: 24560778
[TBL] [Abstract][Full Text] [Related]
14. CDP-choline attenuates scopolamine induced disruption of prepulse inhibition in rats: involvement of central nicotinic mechanism.
Uslu G; Savci V; Buyukuysal LR; Goktalay G
Neurosci Lett; 2014 May; 569():153-7. PubMed ID: 24708927
[TBL] [Abstract][Full Text] [Related]
15. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia.
Paranos SLj; Tomić MA; Micov AM; Stepanović-Petrović RM
Fundam Clin Pharmacol; 2013 Jun; 27(3):319-28. PubMed ID: 22136176
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats.
Yoon H; Kim MJ; Yoon I; Li DX; Bae H; Kim SK
Biol Pharm Bull; 2015; 38(5):710-4. PubMed ID: 25752933
[TBL] [Abstract][Full Text] [Related]
18. Antihypersensitivity effects of tramadol hydrochloride in a rat model of postoperative pain.
Kimura M; Obata H; Saito S
Anesth Analg; 2012 Aug; 115(2):443-9. PubMed ID: 22575568
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
20. Antihyperalgesic effects of myrsinoic acid B in pain-like behavior induced by inflammatory and neuropathic pain models in mice.
Antonialli Cde S; da Silva GF; Rocha LW; Monteiro ER; de Souza MM; Malheiros A; Yunes RA; Quintão NL
Anesth Analg; 2012 Aug; 115(2):461-9. PubMed ID: 22523418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
